ACHN News 12.17 09/08/2014 04:23:45 Achillion Pharmaceuticals

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Achillion Pharmaceuticals (ACHN) 12.17 $ACHN

Most active Nasdaq-traded stocks
AP - Fri Sep 05, 2:45PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at 1 p.m.:

Nasdaq stocks posting largest percentage decreases
AP - Fri Sep 05, 2:45PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:

Biotech Stock Mailbag: Achillion, Ariad Revisited, Endocyte
at The Street - Fri Sep 05, 7:55AM CDT
Biotech columnist Adam Feuerstein answers readers' questions about health care.

Why Achillion Pharmaceuticals (ACHN) Stock Might be a Great Pick - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Sep 05, 7:33AM CDT
Achillion Pharmaceuticals belongs to the Medical industry, is a decent pick as it witnessed solid earnings estimate revision activity with a favorable Zacks Industry Rank.

Market Maker Surveillance Report. GILD, GE, SLM, ACHN, WU, SREV, Bullishly Biased Price Friction For Wednesday, September 3rd 2014
M2 - Thu Sep 04, 10:02AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 4918 companies with "abnormal" market making, 2306 companies with positive Friction Factors and 2830 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bullish bias) in their stock prices. This means that there was more selling than buying in the stocks and their stock prices rose. GILEAD SCIENCES, INC. (NASDAQ:GILD), General Electric Co (NYSE:GE), SLM Corp (NASDAQ:SLM), Achillion Pharmaceuticals Inc (NASDAQ:ACHN), Western Union Co (NYSE:WU), SERVICESOURCE INTERNATIONAL INCORPORATED (NASDAQ:SREV). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

'Mad Money' Lightning Round: I'm Taking Verizon Over AT&T
at The Street - Wed Sep 03, 5:00AM CDT
Cramer prefers Dow Chemicals to FMC and MGM Resorts to Las Vegas Sands.

Jim Cramer's 'Mad Money' Recap: The 2012 Stock Market All Over Again
at The Street - Tue Sep 02, 6:49PM CDT
Investors are dumping the industrial and technology stocks in favor of anything domestic, including health care, transportation, restaurants and entertainment, Cramer says.

Reveal Insider Trading for Facebook, Plug Power, Achillion Pharmaceuticals, Apple, Twitter, and Intel
PR Newswire - Tue Sep 02, 7:55AM CDT
Today, Insiderslab.com revealed the latest insider trading research for Facebook (NASDAQ: FB), Plug Power (NASDAQ: PLUG), Achillion Pharmaceuticals (NASDAQ: ACHN), Apple (NASDAQ: AAPL), Twitter (NYSE: TWTR), and Intel (NASDAQ:INTC). US stock investors can access these reports through the links below, including stock performance, insider trading signals, and visual results.

Four biotech takeover targets?
at Investor's Business Daily - Fri Aug 29, 5:58PM CDT
Following the news that Roche (RHHBY) is acquiring InterMune (ITMN) for $8.3 bil, other takeover talk has started to stir, leading to speculation that Achillion Pharmaceuticals (ACHN), Intercept Pharmaceuticals (ICPT), Puma Biotechnology (PBYI) and...

4 Biotechs That Might Be Bought Soon
at Investor's Business Daily - Fri Aug 29, 10:53AM CDT
The recent announcement that Roche (RHHBY) will buy InterMune (ITMN) for $8.3 billion brought new life to M&A speculation in the biotech industry, which had been relatively neglected as the buzz focused on tax-inversion deals by biopharmaceutical...

Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Aug 27, 9:32AM CDT
Roche's agreement to acquire InterMune has raised hopes for more such deals in the biotech sector.

The Zacks Analyst Blog Highlights: Roche, InterMune, Achillion Pharmaceuticals, Puma Biotechnology and Intercept Pharmaceuticals
PR Newswire - Wed Aug 27, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Roche (OTC:RHHBY-Free Report), InterMune (Nasdaq:ITMN-Free Report), Achillion Pharmaceuticals (Nasdaq:ACHN-Free Report), Puma Biotechnology (NYSE BYI-Free Report) and Intercept Pharmaceuticals (Nasdaq:ICPT-Free Report).

Achillion Pharmaceuticals (ACHN) Jumps: Stock Adds 9% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Aug 27, 7:37AM CDT
Achillion Pharmaceuticals, Inc. (ACHN) was a big mover last session, as the company saw its shares rise 9% on the day.

Achillion Pharmaceuticals (ACHN) Stock Hits New One-Year High
at The Street - Tue Aug 26, 11:10AM CDT
Achillion Pharmaceuticals (ACHN) touched another 52-week high of $12 on Tuesday after UBS tabbed the company as a possible takeover target.

3 Biotechs Surging Following InterMune Takeover - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 10:07AM CDT
InterMune 's (ITMN) impending acquisition by Roche (RHHBY) caused many mid-cap biotechs to rise.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tune In for Post Holdings' Earnings Call this November

Updated Category News Views 2

Crunch Time for Post Holdings: Earnings Insight Well folks, pull out your calendars because November 20 is shaping up to be a big day for those tracking Post Holdings, Inc. (NYSE:POST). If you're in the game, this upcoming conference call is your prime chance to get the scoop on how the numbers stack up for Q4 and what's brewing for fiscal year 2027. This isn't some...

Continue Reading
Visteon Reports Q3 2026 Results with Mixed Signals

Updated Category News Views 1

Visteon's Q3 2026 Financial Performance: Insights and Implications You'd think by now that anything to do with supply chain hiccups wouldn’t surprise me, but Visteon Corporation’s recent third quarter results got my gears grinding yet again. Here's the scoop: Visteon pulled in $970 million in sales, strutting around with a 10% growth-over-market. Their resilience...

Continue Reading
Mixed Wage Growth: Gains for Some, Challenges Persist

Updated Category News Views 3

A Closer Look at Q3 Earnings I tell you, these numbers from the Ludwig Institute make for a pretty mixed bag. Sure, we got a slight nudge upwards in those median weekly earnings for the third quarter, like from $1,035 to $1,041. It’s a pinch of positive news, but hang on a sec before you start celebrating. The reality ain't shifting for a lot of folks, especially if...

Continue Reading
AmeriTrust's Medicaid Platform Reaches All U.S. States

Updated Category News Views 3

Breaking New Ground in Medicaid Applications Brace yourself, healthcare folk! AmeriTrust Solutions just rolled out its Medicaid application platform across all 50 states, and not a minute too soon. With the ink still wet on H.R.1, hospitals and revenue cycle management (RCM) partners need all the help they can get navigating Medicaid's twisting corridors. AmeriTrust is...

Continue Reading
Bybit AI Unveils Personal Finance Customization Spree

Updated Category News Views 6

What’s New with Bybit AI In a world of cookie-cutter financial platforms, Bybit's latest move feels like a breath of fresh air. Bybit AI isn’t just about rolling out another digital assistant; it's bringing a whole new level to the playing field by letting users create a truly personalized financial journey. It's no wonder they’re backed by a colossal user base of...

Continue Reading
Data Center Piping Surges With AI Cooling to $4.5B

Updated Category News Views 3

Liquid Cooling Revolutionizes Data Center Infrastructure Gotta hand it to the tech world, when it decides to shift, it shifts hard and fast. The data center piping market isn't just keeping up—it's sprinting. The move towards liquid-cooled AI setups isn’t just a trend; it’s a defining transformation. With a projected explosion to a $4.5 billion market by 2035, you...

Continue Reading
Lazard's Q3 2026: Surging Revenue, Waning Net Income

Updated Category News Views 5

Breaking Down the Numbers Lazard just dropped its Q3 2026 earnings report, and you can smell both optimism and caution in the air. Sure, $814 million in net revenue isn’t anything to sneeze at, especially when it’s a neat 9% jump from last year’s $748 million. Adjusted figures were a whisker away at $805 million. But dig deeper, and things get a tad less rosy—net...

Continue Reading
Better Home's Litigation Storm: Investor Alert for Stakeholders

Updated Category News Views 2

Legal Murmurs Rock Better Home & Finance Like an old ship caught in a storm, Better Home & Finance Holding Company (NASDAQ: BETR) finds itself teetering on unstable seas. Investors got blindsided by a dramatic 28.5% drop in stock value on May 7, 2026, following revelations from the company's first-quarter earnings call that investors aren't likely to forget anytime soon....

Continue Reading
AMTD Digital's Half-Year Results Stir Investor Interest

Updated Category News Views 4

AMTD Digital Warming Up for a Busy Quarter Some things just catch the wind differently in the market, and when a heavyweight like AMTD Digital starts talking numbers, everybody perks up. They're gearing up to drop their half-year financials, ready to roll out at the stroke of midnight on October 23rd, and investor ears across the globe are pricked for what’s coming down...

Continue Reading
FIBRA Prologis Posts Strong Q3 2026 Results Amid Market Trends

Updated Category News Views 5

Decoding FIBRA Prologis' Latest Numbers Never a dull moment in industrial real estate, folks—and FIBRA Prologis (BMV:FIBRAPL 14) just dropped its third quarter earnings results for 2026, lighting a fire in its trajectory. On the surface, their numbers seem to belt out a victory anthem, but let's peel back the layers to understand what truly hums under the hood. A...

Continue Reading

Top 5 Most Recently Viewed Articles

Eco Wave Power Moves Ahead with Landmark Wave Energy Project

Updated Category News Views 337

Eco Wave Power Secures Final Permit for Wave Project Eco Wave Power Global AB (NASDAQ: WAVE) is thrilled to announce that it has successfully obtained the final Nationwide Permit (NWP) from the U.S. Army Corps of Engineers for its innovative wave energy project. This groundbreaking initiative is set to take place at the Port of Los Angeles, representing a significant leap...

Continue Reading
XOMA Royalty Closes Acquisition of LAVA Therapeutics Shares

Updated Category News Views 176

XOMA Royalty Concludes Acquisition of LAVA Therapeutics In a landmark move, XOMA Royalty Corporation (Nasdaq: XOMA) has announced the completion of its acquisition of LAVA Therapeutics N.V. (NASDAQ: LVTX). This acquisition involved the purchase of all outstanding common shares of LAVA, valued at €0.12 each, with shareholders receiving $1.04 in cash for each share as...

Continue Reading
Medical Displays Market: Unlocking Growth Opportunities Ahead

Updated Category News Views 96

Medical Displays Market Overview The global medical displays market is on an impressive growth trajectory, with a projected valuation estimated to reach US$3.45 billion. This noteworthy surge from US$2.50 billion, which marked the market's value in 2024, is attributed to several key factors. The ongoing rise in chronic diseases, coupled with an aging population and...

Continue Reading
Jim Belushi's Farm Debuts Signature Cannabis Strains

Updated Category News Views 445

Belushi's Farm Introduces Exciting Cannabis Strains Jim Belushi, the acclaimed cannabis advocate and founder of Belushi's Farm, is thrilled to announce a partnership with Wondergrove, enhancing their reach by introducing signature strains across Ohio. This initiative is a part of a broader movement towards sustainable, high-quality cannabis cultivation that emphasizes...

Continue Reading
TRX Gold's Spectacular Year-End Performance Fuels Growth Plans

Updated Category News Views 159

Strong Year-End Results from TRX Gold TRX Gold Corporation (TSX: TRX) has recently shared its impressive fourth quarter results alongside key highlights from the fiscal year ending August 31, 2025. Demonstrating a solid financial performance, the Company achieved remarkable milestones that include record gold production and substantial revenues, setting the stage for an...

Continue Reading